Clinical Trials
41 trialsMT2021-08T Cell Receptor Alpha/Beta Depletion PBSC Transplantation for Heme Malignancies
Masonic Cancer Center, University of Minnesota
(HEM-FLU)
Asan Medical Center
A Study to Evaluate the Intratumoral Influenza Vaccine Administration in Patients With Breast Cancer
Rush University Medical Center
Baloxavir and Oseltamivir for the Treatment of Severe Influenza Infection in Immunocompromised Patients
M.D. Anderson Cancer Center
BRAVO
University of Florida
VRiC
Abramson Cancer Center at Penn Medicine
VSMART
University of Miami
BENEFIT-C
Tulane University
High Dose Flu Vaccine in Treating Children Who Have Undergone Donor Stem Cell Transplant
Vanderbilt-Ingram Cancer Center
Safety and Efficacy of Concurrent Administration of Influenza Vaccine in Patients Undergoing Anti-PD-1 Immunotherapy (Nivolumab, Pembrolizumab)
Wake Forest University Health Sciences
Study of the Immune Response After Vaccination in Multiple Myeloma Patients
Wake Forest University Health Sciences
HMvax-Regist
Wake Forest University Health Sciences
MOSAIC
Imperial College London
INFLUENCE
Herlev Hospital
SYS01
University Hospital Tuebingen
Study to Determine if the Flu Vaccine Increases the Risk of Muscle Damage in Participants Taking Drugs That Block Certain Proteins Made by Some Types of Immune System Cells
Bristol-Myers Squibb
A Pilot Study of Influenza Viruses Isolated From Immunocompromised Children and Adolescents
St. Jude Children's Research Hospital
PTN_POPS
Duke University
Impact of the Qatar 2022 FIFA World Cup on PED Use and Misuse Patterns
Pediatric Clinical Research Platform
BRANCH-P
Willows Health
Impact of Inactivated Trivalent Influenza Vaccine on NSCLC Patients Receiving PD-1 / PD-L1 Inhibitors
Shanghai Pulmonary Hospital, Shanghai, China
Treatment of Severe Influenza A Infection
The University of Hong Kong
Influenza Vaccination in Patients Receiving Immune Checkpoint Inhibitor
Seoul National University Hospital
SHIVERING 2
Yale University
Lenalidomide as Immune Adjuvant in Patient's With Chronic Lymphocytic Leukemia (CLL)
M.D. Anderson Cancer Center
Volatolome
University of Latvia
Influenza Vaccine Post Allogeneic Transplant
Masonic Cancer Center, University of Minnesota
Safety Study to Evaluate FluMist in Immunocompromised Children
MedImmune LLC
Immunogenicity of Fluzone HD,A High Dose Influenza Vaccine, In Children With Cancer or HIV
St. Jude Children's Research Hospital
IMMUNE
Rochester General Hospital
Influenza Vaccination in Cancer Patients
Seoul National University Hospital
UARK 2009-99 A Non-interventional Observational Study of Infectious Complications in Cancer Patients
University of Arkansas
Trivalent Baculovirus-expressed Influenza HA Vaccine in Adults With Non-Hodgkin's B-cell Lymphoma
National Institute of Allergy and Infectious Diseases (NIAID)
Rituxivac
St. Antonius Hospital
Optimizing Influenza Vaccination in Surgical Oncology Patients
Stony Brook University
Effectiveness of a Vaccination Program in the Community Ob/Gyn Setting
Duke University
Clinical Trial to Compare the Immunogenicity, Safety, and Tolerability of an Adjuvanted A(H1N1) Influenza Vaccine Versus Non-Adjuvanted A(H1N1) Influenza Vaccines in Patients With Invasive Solid Tumors
Chiltern Pesquisa Clinica Ltda
Reactogenicity, Immunogenicity of Trivalent Influenza Vaccine With Recombinant Interferon Alpha Among Chronic Lymphocytic Leukemia
M.D. Anderson Cancer Center
Influenza Vaccination in Patients Receiving Antineoplastic Therapy for Non-Hodgkin's Lymphoma
M.D. Anderson Cancer Center
FMRESP
St. Jude Children's Research Hospital
Evaluation of Influenza H1N1 Vaccine in Adults With Lymphoid Malignancies on Chemotherapy
University Health Network, Toronto